Can fake ayurveda medicines cure sexual disorders, impotency? Seizures by Drug Control Admn

HYDERABAD: The Telangana Drugs Control Administration (DCA) has seized eight varieties of ayurvedic medicines from Nalgonda for making misleading claims on their labels and violating the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

The medicines, manufactured by Lifecare Ayurvedic from Rajasthan, made claims to treat diabetes, kidney stones, sexual impotence, obesity, asthma, menstrual disorders, and vision problems, which are prohibited under the Act.

The seized products are

  • Diab Amrit Capsules (claimed to treat diabetes)
  • Stone Crush Capsules and Syrup (claimed to treat kidney stones)
  • Sleemocare Kit Powder and Capsule (claimed to treat obesity)
  • Sperm Grow Kit Powder and Capsule (claimed to treat sexual impotence)
  • Migrocare Capsules (claimed to treat vision problems)
  • Cysto Care Syrup (claimed to treat irregular menstruation)
  • Asthma Care Capsules (claimed to treat asthma)

The raid took place at Sri Siddhi Vinayaka Medical Hall in Nalgonda. DCA officials said that the seized medicines were worth Rs 2,750.

“Persons who make misleading advertisements regarding drugs for treatment of certain diseases and disorders are punishable under Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, with imprisonment which may extend to six months, or with fine, or with both,” the DCA said.

The authorities said that further investigation was underway and action would be taken against all offenders as per the law.

Related Posts

  • Pharma
  • June 17, 2025
  • 99 views
Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Bengaluru-based biopharmaceutical firm Biocon on Monday launched a qualified institutions placement (QIP) to raise Rs 4,500 crore. As part of the offering, the firm will issue up to 139 million…

  • Pharma
  • June 17, 2025
  • 102 views
Zydus Healthcare appoints Swati Dalal MD

Zydus Lifesciences Ltd on Monday announced the appointment of Swati Dalal as an additional director and Managing Director of its wholly-owned arm Zydus Healthcare Ltd. The board of Zydus Healthcare…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Zydus Healthcare appoints Swati Dalal MD

Zydus Healthcare appoints Swati Dalal MD

Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

Natco API plant gets one observation from FDA

Natco API plant gets one observation from FDA